These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12466073)

  • 1. [Effects of corticosteroids in the management of Duchenne muscular dystrophy: our experience].
    Rafia S; Pascual-Pascual SI; Martínez-Granero MA; Pascual-Castroviejo I
    An Esp Pediatr; 2002 Dec; 57(6):518-23. PubMed ID: 12466073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability and trends in corticosteroid use by male United States participants with Duchenne muscular dystrophy in the Duchenne Registry.
    Cowen L; Mancini M; Martin A; Lucas A; Donovan JM
    BMC Neurol; 2019 May; 19(1):84. PubMed ID: 31046703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroid therapy for duchenne muscular dystrophy: improvement of psychomotor function.
    Sato Y; Yamauchi A; Urano M; Kondo E; Saito K
    Pediatr Neurol; 2014 Jan; 50(1):31-7. PubMed ID: 24138948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral corticosteroids and onset of cardiomyopathy in Duchenne muscular dystrophy.
    Barber BJ; Andrews JG; Lu Z; West NA; Meaney FJ; Price ET; Gray A; Sheehan DW; Pandya S; Yang M; Cunniff C
    J Pediatr; 2013 Oct; 163(4):1080-4.e1. PubMed ID: 23866715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy.
    King WM; Ruttencutter R; Nagaraja HN; Matkovic V; Landoll J; Hoyle C; Mendell JR; Kissel JT
    Neurology; 2007 May; 68(19):1607-13. PubMed ID: 17485648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Steroid Therapy in Duchenne Muscular Dystrophy-Positive Results versus Side Effects.
    Schara U; Mortier ; Mortier W
    J Clin Neuromuscul Dis; 2001 Jun; 2(4):179-83. PubMed ID: 19078632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management.
    Moxley RT; Pandya S; Ciafaloni E; Fox DJ; Campbell K
    J Child Neurol; 2010 Sep; 25(9):1116-29. PubMed ID: 20581335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of steroids on surgical experiences of patients with duchenne muscular dystrophy.
    Dooley JM; Gordon KE; MacSween JM
    Pediatr Neurol; 2010 Sep; 43(3):173-6. PubMed ID: 20691938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
    Gloss D; Moxley RT; Ashwal S; Oskoui M
    Neurology; 2016 Feb; 86(5):465-72. PubMed ID: 26833937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends with corticosteroid use in males with Duchenne muscular dystrophy born 1982-2001.
    Fox DJ; Kumar A; West NA; DiRienzo AG; James KA; Oleszek J;
    J Child Neurol; 2015 Jan; 30(1):21-6. PubMed ID: 24682290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroids in Duchenne muscular dystrophy: impact on the motor function measure sensitivity to change and implications for clinical trials.
    Schreiber A; Brochard S; Rippert P; Fontaine-Carbonnel S; Payan C; Poirot I; Hamroun D; Vuillerot C;
    Dev Med Child Neurol; 2018 Feb; 60(2):185-191. PubMed ID: 28990163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
    Moxley RT; Ashwal S; Pandya S; Connolly A; Florence J; Mathews K; Baumbach L; McDonald C; Sussman M; Wade C; ;
    Neurology; 2005 Jan; 64(1):13-20. PubMed ID: 15642897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics and emerging treatments for Duchenne and Becker muscular dystrophy.
    Wein N; Alfano L; Flanigan KM
    Pediatr Clin North Am; 2015 Jun; 62(3):723-42. PubMed ID: 26022172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Duchenne muscular dystrophy with ciclosporin A: a randomised, double-blind, placebo-controlled multicentre trial.
    Kirschner J; Schessl J; Schara U; Reitter B; Stettner GM; Hobbiebrunken E; Wilichowski E; Bernert G; Weiss S; Stehling F; Wiegand G; Müller-Felber W; Thiele S; Grieben U; von der Hagen M; Lütschg J; Schmoor C; Ihorst G; Korinthenberg R
    Lancet Neurol; 2010 Nov; 9(11):1053-9. PubMed ID: 20801085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between timing of corticosteroid treatment initiation and clinical outcomes in Duchenne muscular dystrophy.
    Kim S; Zhu Y; Romitti PA; Fox DJ; Sheehan DW; Valdez R; Matthews D; Barber BJ;
    Neuromuscul Disord; 2017 Aug; 27(8):730-737. PubMed ID: 28645460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroids in Duchenne muscular dystrophy: a reappraisal.
    Wong BL; Christopher C
    J Child Neurol; 2002 Mar; 17(3):183-90. PubMed ID: 12026233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of corticosteroids in a population-based cohort of boys with duchenne and becker muscular dystrophy.
    Matthews DJ; James KA; Miller LA; Pandya S; Campbell KA; Ciafaloni E; Mathews KD; Miller TM; Cunniff C; Meaney FJ; Druschel CM; Romitti PA; Fox DJ;
    J Child Neurol; 2010 Nov; 25(11):1319-24. PubMed ID: 20207610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Mixed-Method Study Exploring Patient-Experienced and Caregiver-Reported Benefits and Side Effects of Corticosteroid Use in Duchenne Muscular Dystrophy.
    Fischer R; Porter K; Donovan JM; Scavina MT; Armstrong N; Denger B; Hasham S; Peay H
    J Neuromuscul Dis; 2023; 10(4):593-613. PubMed ID: 37182893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fracture in Duchenne Muscular Dystrophy: Natural History and Vitamin D Deficiency.
    Perera N; Sampaio H; Woodhead H; Farrar M
    J Child Neurol; 2016 Aug; 31(9):1181-7. PubMed ID: 27221372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic intracranial hypertension in a child with Duchenne muscular dystrophy.
    Weig SG; Zinn MM; Howard JF
    Pediatr Neurol; 2011 Dec; 45(6):406-8. PubMed ID: 22115006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.